Literature DB >> 3412587

A comparison of clinical and pathological features of young- and old-onset Parkinson's disease.

W R Gibb1, A J Lees.   

Abstract

We compared 46 patients having onset of Parkinson's disease before age 45 years with 52 having onset after age 70. Young-onset cases more often presented with muscular stiffness (43%) and old-onset with difficulty walking (33%). One-third of young-onset cases had off-period dystonia, mostly affecting the legs, but no dystonia was recorded in old-onset cases. Presentation with rest tremor occurred in 41% of young-onset and 63% of old-onset. There were no differences in the number of affected relatives, endocrine disease, personality characteristics, dementia, or dyskinesia. A pathological study of 12 young-onset and 22 old-onset cases showed 24% greater nigral cell loss in the young, but no differences in the basic Lewy body pathology. Median disease duration in young cases was 5 years longer in the clinical study and 12 years longer in the pathological study. These studies show that the Parkinson's disease process is similar in young- and old-onset cases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3412587     DOI: 10.1212/wnl.38.9.1402

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  79 in total

Review 1.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 2.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

3.  Attention modulation regulates both motor and non-motor performance: a high-density EEG study in Parkinson's disease.

Authors:  B Perfetti; C Moisello; S Lanzafame; S Varanese; E C Landsness; M Onofrj; A Di Rocco; G Tononi; M F Ghilardi
Journal:  Arch Ital Biol       Date:  2010-09       Impact factor: 1.000

4.  Patterns of striatal functional connectivity differ in early and late onset Parkinson's disease.

Authors:  Yanbing Hou; Jing Yang; Chunyan Luo; Ruwei Ou; Wei Song; Wanglin Liu; Qiyong Gong; Huifang Shang
Journal:  J Neurol       Date:  2016-07-09       Impact factor: 4.849

Review 5.  The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.

Authors:  Wei-Xi Xiong; Yi-Min Sun; Rong-Yuan Guan; Su-Shan Luo; Chen Chen; Yu An; Jian Wang; Jian-Jun Wu
Journal:  J Neurol       Date:  2016-07-08       Impact factor: 4.849

6.  Estimated life expectancy of Parkinson's patients compared with the UK population.

Authors:  Lianna S Ishihara; Anne Cheesbrough; Carol Brayne; Anette Schrag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-30       Impact factor: 10.154

7.  Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.

Authors:  Paola Costa-Mallen; Christopher Gatenby; Sally Friend; Kenneth R Maravilla; Shu-Ching Hu; Kevin C Cain; Pinky Agarwal; Yoshimi Anzai
Journal:  J Neurol Sci       Date:  2017-04-23       Impact factor: 3.181

8.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Debbie Lombard; Rene Veikondis; Jonathan Carr; Soraya Bardien
Journal:  Neurogenetics       Date:  2009-12-15       Impact factor: 2.660

9.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

10.  Identification of a novel functional deletion variant in the 5'-UTR of the DJ-1 gene.

Authors:  Rowena J Keyser; Lize van der Merwe; Mauritz Venter; Craig Kinnear; Louise Warnich; Jonathan Carr; Soraya Bardien
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.